Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 253
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Comparing Psilocybin Mushroom Bruising with Trichoderma Infection
PT250 – Matt Ball – New Frameworks For Schizophrenia, Dissociation, and...
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and...
COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in...
Lobe Sciences Appoints Charles Grob, MD to Scientific Advisory Board
Awakn Life Sciences Files Patent Applications In U.S. For AWKN001 And...
MindMed Included in FTSE Russell 3000® Index
Psychedelic Bulletin: Ex-FDA Psychiatry Director Joins Cybin as Advisor; Texas Approves...
Psychedelic Treatment for Eating Disorder Recovery
PTSF65 – Navigating Psychedelics for Clinicians and Therapists, and Nitrous Oxide...
Load more